Elevance Health Inc Scores 81% on Multi-Factor Investor Model

Elevance Health Inc receives an 81% rating under a multi-factor investment strategy, indicating strong fundamentals and valuation. However, its final rank shows weaknesses, which may impact investor sentiment.

Date: 20-09-2024

AI Rating: 5

Earnings Per Share (EPS): Not mentioned in the report.

Revenue Growth: Not mentioned in the report.

Net Income: Not mentioned in the report.

Profit Margins: Not mentioned in the report.

Free Cash Flow (FCF): Not mentioned in the report.

Return on Equity (ROE): Not mentioned in the report.

Market Cap: The report indicates that Elevance Health Inc passes the market cap test, a positive signal as it is considered a large-cap growth stock.

Standard Deviation: The company also passes the standard deviation test, another positive signal reflecting lower volatility.

Momentum and Net Payout Yield: The reports' assessments on twelve minus one momentum and net payout yield are neutral. This indicates stability but does not suggest strong growth potential.

Final Rank: Despite the overall positive scores in several categories, the final rank is a failure. This implies that, while the company shows promise, there are significant concerns that investors may need to consider.

Overall, while Elevance Health Inc's strong rating of 81% indicates interest based on underlying fundamentals and stock valuation, the failing final rank suggests caution. Investment sentiment may be affected as investors weigh the positives against the underlying weaknesses.

Stocks: ELV